J&J Rebuffs Settlement Talks In Patent Dispute With Boston Scientific

Law360, New York (June 17, 2005, 12:00 AM EDT) -- Johnson & Johnson has rebuffed an offer to begin settlement talks by rival Boston Scientific in their patent dispute over drug-coated stents, Boston Scientific told the Boston Globe.

A J&J spokesman declined to comment on the remarks, which were attributed to a spokesman for Boston Scientific, according to the newspaper.

The report comes amid amid ongoing trials in Delaware between the companies involving patents on their competing drug-coated cardiac stents used to treat clogged arteries.

Separately, a J&J spokesman told the newspaper he couldn't comment on...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.